Title : Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma.

Pub. Date : 2003

PMID : 14686975






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Orally administered bexarotene, the first synthetic highly selective retinoid-X-receptor retinoid to be approved by the FDA for CTCL, was shown to be active against the cutaneous manifestations of all stages of CTCL. Bexarotene TSPY like 2 Homo sapiens
2 Orally administered bexarotene, the first synthetic highly selective retinoid-X-receptor retinoid to be approved by the FDA for CTCL, was shown to be active against the cutaneous manifestations of all stages of CTCL. Bexarotene TSPY like 2 Homo sapiens
3 Bexarotene treatment induces apoptosis of CTCL cells with down-regulation of its receptors and of survivin, an inhibitor of apoptosis. Bexarotene TSPY like 2 Homo sapiens